ANTIPHONICS IVS: Financial statements 2017
CVR: 35651543
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ANTIPHONICS IVS (CVR 35651543) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 41,040 and a net result of DKK 9,340 compared with DKK 15,968 the year before. That is a decrease of 9.4% compared with the year before. The profit margin was 22.8%. Equity in the 2017 report amounted to DKK 23,908. The solvency ratio was 98.1%.
- Revenue
- DKK 41,040
- Gross Profit
- DKK 13,597
- Profit/Loss
- DKK 9,340
- Equity
- DKK 23,908
- Total Assets
- DKK 24,367
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 41 t. | 14 t. | 9 t. | 24 t. | - |
| 2016 | 45 t. | 21 t. | 16 t. | 40 t. | - |
| 2015 | 75 t. | 22 t. | -6 t. | 63 t. | - |
| 2014 | 34 t. | -39 t. | -57 t. | 57 t. | - |
Official annual report
Keep an eye on ANTIPHONICS IVS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ANTIPHONICS IVS has published its annual report for 2016. Revenue came to DKK 45,312, and the net result was DKK 15,968.
About ANTIPHONICS IVS
ANTIPHONICS IVS was a Danish company of the type Iværksætterselskab based in Herlev, founded in 2014. The company has been dissolved on 2 December 2021. The company was registered under the industry Indspilning af lydoptagelser og udgivelse af musik. In 2020, the company reported revenue of DKK 11,726 and a net result of DKK -7,946 compared with DKK -6,694 the year before. Equity in the 2020 report amounted to DKK 122,533.